Testing effectiveness (Phase 2)Active Not RecruitingNCT05350592
What this trial is testing
Low-Dose Dobutamine and Single-Dose Tocilizumab in Acute Myocardial Infarction With High Risk of Cardiogenic Shock
Who this might be right for
Acute Myocardial InfarctionCardiogenic Shock
Rigshospitalet, Denmark 100